title: Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold?
authors.forename: Dario
authors.initials: D
authors.lastname: Sorrentino
authors.forename: Graham
authors.initials: G
authors.lastname: Radford-Smith
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000963:Antimetabolites / Q000008:administration & dosage*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000963:Antimetabolites; D005765:Gastrointestinal Agents